Protecting First Responders January 9, 2016 • admin • Keeping our heroes safe from the dangers of chemical exposures. Related News Countervail Presents at Annual CounterACT Meeting June 15, 2016 Pre-IND FDA Meeting held to obtain guidance on development of galantamine as a pre-treatment for nerve agent exposure. March 17, 2009
